Ongoing monitoring for women on ert includes 1 lipid

Ongoing monitoring for women on ERT includes:
1. Lipid levels, repeated annually if abnormal
2. Annual health history & review of risk profile
3. Annual mammogram
4. All of the above
7.
Kristine would like to start HRT to treat the significant vasomotor symptoms she is experiencing during menopause. Education for a
woman considering hormone replacement would include:
1
.
Explaining that HRT is totally safe if used short term
2
.
Telling her to ignore media hype regarding HRT
3
.
Discussing the advantages & risks of HRT
4
.
Encouraging the patient to use phytoestrogens with the HRT
8.
Angela is a black woman who has heard that women of African descent do not need to worry about osteoporosis. What education would
you provide Angela about her risk?
1
.
She is correct, black women do not have much risk of developing osteoporosis
due to their dark skin.
2
.
Black women are at risk of developing osteoporosis due to their lower calcium
intake as a group.
3
.
If she doesn’t drink alcohol, her risk of developing osteoporosis is low.
4
.
If she has not lost more than 10% of her weight lately, her risk is low.
9.
Drugs that increase the risk of osteoporosis developing include:
1
.
Oral combined contraceptives
2
.
Carbamazepine
3
.
Calcium channel blockers
4
.
High doses of vitamin D
10.
Selective estrogen receptor modifiers (SERMs) treat osteoporosis by selectively:
1
.
Inhibiting magnesium resorption in the kidneys
2
.
Increasing calcium absorption from the GI tract
3
.
Acting on the bone to inhibit osteoblast activity
4
.
Selectively acting on the estrogen receptors in the bone
11. Sallie has been diagnosed with osteoporosis & is asking about the “once a month” pill to treat her condition. How do bisphosphonates treat
osteoporosis?
1
.
By selectively activating estrogen pathways in the bone
2
.
By reducing bone resorption by inhibiting parathyroid hormone (PTH)
3
.
By reducing bone resorption & inhibiting osteoclastic activity
4
.
By increasing PTH production
12. Inadequate vitamin D intake can contribute to the development of osteoporosis by:
1
.
Increasing calcitonin production
2
.
Increasing calcium absorption from the intestine
3 Altering calcium metabolism
ADV Pharm | TextBook | StudyGuide 97

.
4
.
Stimulating bone formation
13.
The drug recommended as primary prevention of osteoporosis in women over age 70 years is:
1
.
Alendronate (Fosamax)
2
.
Ib&ronate (Boniva)
3
.
Calcium carbonate
4
.
Raloxifene (Evista)
14. The drug recommended as primary prevention of osteoporosis in men over age 70 years is:
1
.
Alendronate (Fosamax)
2
.
Ib&ronate (Boniva)
3
.
Calcium carbonate
4
.
Raloxifene (Evista)
15. The ongoing monitoring for patients over age 65 years taking alendronate (Fosamax) or any other bisphosphonate is:
1
.
Annual dual-energy x-ray absorptiometry (DEXA) scans
2
.
Annual vitamin D level
3
.
Annual renal function evaluation
4
.